Treatment with GPR183 antagonist NIBR189 significantly suppressed experimental lupus severity, as measured by lower proteinuria score (3.2 in NIBR189-treated mice vs. 1.1 in control lupus mice, p=0.0006). The gene discussed is GPR183; the disease is systemic lupus erythematosus.